In the Prepared Foods article titled “GLP-1 Medications Drive Shifts in Food & Beverage Market,” AMC Global’s Lea Ben-Akiva explores the profound impact that GLP-1 medications like Ozempic, Wegovy, and Mounjaro are having on consumer behavior, particularly within the food and beverage sector as revealed in our recent consumer study. These medications are rapidly becoming more widely used for weight management and diabetes treatment, and they are shaping the way people think about food, what they consume, and how much.
A major theme in the article is the shift towards healthier eating choices among GLP-1 users. As the medications suppress appetite and promote satiety, consumers are opting for smaller portions and making more health-conscious decisions. For instance, sweet snacks, frozen meals, sugary drinks, and alcohol are being replaced with water, whole foods, and nutrient-dense options. This growing focus on health is changing the way consumers view food and is prompting food brands to adjust their offerings.
Another significant trend highlighted in Lea’s article in Prepared Foods is the increasing demand for functional foods. As more GLP-1 users look for products that provide added health benefits, they are seeking out foods rich in vitamins, fiber, and protein. Over 80% of GLP-1 users are now interested in foods that support gut health and offer nutritional boosts. This shift is driving innovation in the food industry as brands work to meet the evolving needs of consumers who are more mindful of the nutritional value of what they consume.
“GLP-1 Medications Drive Shifts in Food & Beverage Market”underscores the opportunity for food and beverage companies to innovate by creating products tailored to the needs of GLP-1 users. With consumers increasingly seeking smaller portion sizes and functional ingredients, there’s a growing market for products that align with these health-conscious choices. Manufacturers who tap into this demand for healthier, functional food options can capitalize on a rapidly growing consumer base.
For a deeper dive into these shifts in consumer behavior and how the food industry can adapt, read the full article here or check out the insights from our consumer study on GLP-1 medication impact.
